Home / Products /Genome Editing /KO Cell Lines /VEGFA Knockout cell line (HEK293)

VEGFA Knockout cell line (HEK293)

Catalog Number: KO00073

Price: Online Inquiry

Specifications KO Solutions KO Cell Line Workflow Handling procedures Downloads Related products

Specifications

Product Information
Product Name VEGFA Knockout cell line (HEK293)
specification 1*10^6
Storage and transportation Dry ice preservation/T25 live cell transportation.
Cell morphology Epithelioid, adherent cell
Passage ratio 1:3~1:6
species Human
Gene VEGFA
Gene ID 7422
Build method Electric rotation method / virus method
Mycoplasma testing Negative
Cultivation system 90%DMEM+10% FBS
Parental Cell Line HEK293
Quality Control Genotype: VEGFA Knockout cell line (HEK293) >95% viability before freezing. All cells were tested and found to be free of bacterial, viruses,mycoplasma and other toxins.
Gene Information
Gene Official Full Name vascular endothelial growth factor Aprovided by HGNC
Also known as VPF; VEGF; MVCD1; L-VEGF
Gene Description This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]
Expression Broad expression in thyroid (RPKM 146.9), prostate (RPKM 69.5) and 21 other tissues See more

KO Solutions

We develop gene knockout solutions tailored to customer requirements and the condition of the target gene.

  • Editing Tools

Cas9 Protein

Cas9 mRNA sgRNA

Cas9 Plasmid

Cas9 Virus

A – Exon KO

gRNAs are designed in the introns flanking the exon, targeting non-multiple-of-3 base deletions in the exon, resulting in frameshift mutations.

B - Frameshift KO

gRNAs are designed within the exon, creating non-multiple-of-3 base deletions to induce frameshift mutations.

C - Complete KO

The entire gene coding sequence is deleted, achieving large-scale knockout effects.

KO Cell Line Workflow

KO Strategy Design

CRISPR Plasmid/Lentiviral Vector Construction

Lentiviral Packaging

Cell Transfection/Lentiviral Infection

Drug Selection

Cell Cryopreservation

Quality Control

Sequencing Validation

Monoclonal Cell Line Generation

Pool Efficiency Validation

Handling procedures

Cell Thawing

  • Pre-warm complete culture medium in a 37°C water bath.
  • Thaw the cryovial in a 37°C water bath for 1–2 minutes.
  • Transfer the cryovial to a biosafety cabinet (BSC) and wipe the surface with 70% ethanol.
  • Loosen the cap and gently transfer the cell suspension into a sterile centrifuge tube containing 9 mL of complete medium.
  • Centrifuge at 125 × g for 5–7 min at room temperature (RT), then discard the supernatant.
  • Resuspend the cell pellet in 5 mL of complete medium and transfer the suspension into a T25 flask.
  • Incubate the cells at 37°C in a 5% CO₂ incubator.
  • Recommended subculturing ratio: 1:2 to 1:3, reaching confluency in 2–3 days.

Cell Passaging

  • When cell confluence reaches 80–90%, proceed with passaging.
  • Pre-warm complete medium, PBS, and trypsin (0.25% Trypsin-EDTA, Gibco 25200-056) in a 37°C water bath. Once near 37°C, spray the bottles with 75% ethanol and place them in the BSC.
  • Retrieve the culture flask from the incubator, spray with 75% ethanol, and transfer it to the BSC.
  • To avoid dislodging cells, gently rinse the monolayer with PBS along the upper wall of the flask. Discard the PBS after washing (use 2 mL for T25 flasks).
  • Add an appropriate volume of trypsin (1.5 mL for T75, 0.5 mL for T25) and gently tilt the flask to ensure full coverage. Adjust the volume as needed. After 1–2 min, when most cells detach, neutralize digestion by adding an equal volume of complete medium. Gently pipette with a 5 mL serological pipette to ensure complete detachment.
  • Transfer the cell suspension to a 15 mL centrifuge tube and spin at 300 × g for 5 min. Discard the supernatant.
  • Resuspend the pellet in 5 mL of complete medium, adjust the seeding ratio as required, and replenish the flask with fresh medium (13–15 mL for T75, 5 mL for T25). Add 1% penicillin-streptomycin (dual antibiotic).
  • Tighten the cap, gently swirl to mix, and place the flask in a 37°C, 5% CO₂ incubator.

Cell Cryopreservation

  • Prepare cryopreservation medium in advance and pre-chill.
  • Ensure cells meet freezing criteria: healthy morphology, late-log phase growth, and absence of contamination or senescence (verify under a microscope).
  • Digest and centrifuge the cells (refer to the passaging protocol).
  • Resuspend the cell pellet in cryopreservation medium (1 mL per vial), mix thoroughly, and aliquot into cryovials.
  • Place the vials in a freezing container and store at −80°C overnight.
  • For long-term storage, transfer the cryovials to a liquid nitrogen tank.

Downloads

Please note that all services are for research use only. Not intended for any clinical use.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.